bluewindmedical

Our publication, “Two-year efficacy and safety outcomes of the pivotal OASIS Study using the Revi® System for treatment of urgency urinary incontinence,” is now available in the @JUrology! Learn more in our press release: bluewindmedical.com/resource/bluew… #Urology #OAB

Heading to #AUA2026 this week? Don’t forget to stop by Booth #4127 to learn more about #Revi – the most clinically validated implantable tibial neuromodulation therapy for Urgency Urinary Incontinence (#UUI). See you there! bluewindmedical.com/providers/clin… @AmerUrological #AUA #Urology #Urogyn

Today, we’ve announced the close of $47.8 million in financing to accelerate commercialization of the Revi® System, the most clinically validated Implantable Tibial Neuromodulation therapy for #UUI. Learn more: businesswire.com/news/home/2026… #Urology #Urogyn

Join us at #AUA2026 to hear Dr. Suzette Sutherland discuss OASIS 3-year outcomes, why subfascial placement matters, and demystify surgical technique for Revi in UUI treatment. #Urology #Urogyn #Revi #Neuromodulation #BladderHealt

#AUA2026 is right around the corner! We’ll be sharing 3-year insights demonstrating the role of personalized programming in optimizing long-term efficacy and patient outcomes. Join us to learn more: bluewindmedical.com/providers/clin… @AmerUrological #AUA #Urology #Urogyn

Now live in The Journal of Medical Economics 📢 A new analysis highlights the cost-effectiveness of implantable tibial neuromodulation (iTNM) as a long-term treatment option for patients with #UUI. Read more: #abstract" target="_blank" rel="nofollow noopener">tandfonline.com/doi/full/10.10… #Urology #Urogyn #Neuromodulation

During #WomensHealthMonth, we’re raising awareness for conditions like #UUI that impact millions of women’s daily lives, often in silence. Learn how innovative solutions are helping women regain control and confidence: bluewindmedical.com/providers/revi… #WomensHealth #Urogyn #Urology

The BlueWind team is gearing up for an exciting #AUA26! We’ll be presenting new 3-year study outcomes demonstrating the impact of The Revi® System’s patient-centric programming: auanet.org/AUA2026 @AmerUrological #AUA #Urology #Urogyn

Now live in The Journal of Urology 📢 Three-year OASIS study data confirm Revi’s unmatched durability, 95% patient satisfaction, and excellent safety, setting a new standard in #UUI care. Read more: auajournals.org/doi/10.1097/JU… @AmerUrological #Urology #ClinicalData #Revi #Neuromodulation

Dr. Roger Dmochowski discusses the transformative impact of #Revi’s 3-year outcomes from the pivotal OASIS trial. Learn more: bluewindmedical.com/providers/clin… #ChooseRevi #Urology #Urogyn #Neuromodulation

#ICYMI: New 3-year OASIS Study results demonstrated The Revi® System’s ability to significantly reduce symptoms for people living with Urgency Urinary Incontinence (#UUI). Learn more: bluewindmedical.com/providers/clin… #ChooseRevi #Urology #Urogyn

“When using the therapy on a daily basis, for a prolonged period of time, we see even more efficacy.” Dr. Sutherland shares how Revi’s at-home convenience and daily therapy lead to improved results for Urgency Urinary Incontinence (#UUI). bluewindmedical.com/resource/dr-su… #Urology #Urogyn

Check out this @UrologyTimes article on new 3-year OASIS study results, which demonstrate consistent efficacy, durability, and patient satisfaction with Revi®. Read more: urologytimes.com/view/revi-impl… #Urology #Neuromodulation #BladderHealth

The BlueWind team is heading to #SESAUA26! We’re looking forward to connecting with our urology colleagues to discuss proven patient-centric treatment options for those living with Urgency Urinary Incontinence (#UUI). Learn more: sesaua.org/home.aspx @SES_AUA #SESAUA #Urology #Urogyn

Looking for a #UUI treatment that lasts? #Revi’s one-time procedure and convenient, personalized therapy offer a long-term solution with 95% patient satisfaction at 3 years. Learn more: bluewindmedical.com/providers/clin… #ChooseRevi #Urology

Urgency Urinary Incontinence (#UUI) can take a significant toll on quality of life. After years without lasting relief, Renee found a new path with Revi®, regaining her confidence and getting back to doing what she loves. ▶️ Learn more: bluewindmedical.com/resource/findi… #Urology #Urogyn

We're thrilled to recognize Dr. Vince Ricchiuti of NEO Urology & Southwoods Health for pioneering #Revi, an innovative new treatment for urge urinary #incontinence. His dedication to advancing treatment will provide a significant impact on his patients' quality of life.

We are excited to announce Dr. Daniel Hoffman of @AdventHealth Medical Group of Orlando FL has performed his first #Revi procedure for patients suffering with urge urinary #incontinence. Thank you for your commitment to improving patients’ quality of life!

🚀What an impactful week we had at #SUFU26! We shared 3-year results from the pivotal OASIS study, reinforcing Revi® as the most clinically validated implantable tibial neuromodulation therapy for #UUI. Learn more: bluewindmedical.com/newsroom/ @sufuorg #SUFU #Urology #Urogyn

We’re excited to announce 3-year results from the pivotal OASIS study, confirming The Revi® System’s sustained efficacy, excellent safety, and exceptional patient satisfaction for urgency urinary incontinence (#UUI). Learn more: businesswire.com/news/home/2026… #Urology #Urogyn

This week at #SUFU26, we’ll be sharing 3-year quality of life outcomes for #UUI patients treated with The Revi® System. Learn more: bluewindmedical.com/providers/clin… @sufuorg #Urology #Urogyn #Neuromodulation